YARROW BIOSCIENCE, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
YARROW BIOSCIENCE, INC. (YARW) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 48.87 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-06
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 48.87M shares, a 359.85% increase year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was -219.92M shares.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 167.74M shares, a 66.40% increase year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 138.65M shares, a 41.48% increase year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 32.42M shares, a 282.06% increase from fiscal 2019.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 8.48M shares, a 31.22% increase from fiscal 2018.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 6.47M shares, a 26.58% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 5.11M shares, a 2.43% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 48.87M shares 10-Q · filed 2021-05-06 | -85.53M shares derived: average of 2 quarters · filed 2021-05-06 | -1.10M shares derived: average of 3 quarters · filed 2021-05-06 | 33.84M shares derived: average of 4 quarters · filed 2021-05-06 | ||||
| 2020-12-31 | -219.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -26.09M shares derived: average of 2 quarters · filed 2021-03-04 | 28.82M shares derived: average of 3 quarters · filed 2021-03-04 | 32.42M shares 10-K · filed 2021-03-04 | ||||
| 2020-09-30 | 167.74M shares 10-Q · filed 2020-11-05 | 153.19M shares derived: average of 2 quarters · filed 2020-11-05 | 116.53M shares 10-Q · filed 2020-11-05 | 14.25M shares derived: average of 4 quarters · filed 2021-05-06 | ||||
| 2020-06-30 | 138.65M shares 10-Q · filed 2020-08-06 | 90.63M shares 10-Q · filed 2020-08-06 | -36.92M shares derived: average of 3 quarters · filed 2021-05-06 | -2.49M shares derived: average of 4 quarters · filed 2021-05-06 | ||||
| 2020-03-31 | 10.63M shares 10-Q · filed 2021-05-06 | 42.51M shares 10-Q · filed 2020-05-11 | -124.70M shares derived: average of 2 quarters · filed 2021-05-06 | -49.53M shares derived: average of 3 quarters · filed 2021-05-06 | -12.65M shares derived: average of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -260.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -79.61M shares derived: average of 2 quarters · filed 2021-03-04 | -20.41M shares derived: average of 3 quarters · filed 2021-03-04 | 8.48M shares 10-K · filed 2021-03-04 | 23.82M shares 10-K · filed 2020-03-03 | |||
| 2019-09-30 | 100.81M shares 10-Q · filed 2020-11-05 | 23.96M shares 10-Q · filed 2019-10-31 | 99.40M shares derived: average of 2 quarters · filed 2020-11-05 | 97.99M shares 10-Q · filed 2020-11-05 | 23.71M shares 10-Q · filed 2019-10-31 | 48.35M shares derived: average of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | 98.00M shares 10-Q · filed 2020-08-06 | 23.89M shares 10-Q · filed 2019-08-01 | 97.95M shares 10-Q · filed 2020-08-06 | 23.59M shares 10-Q · filed 2019-08-01 | 30.86M shares derived: average of 3 quarters · filed 2021-03-04 | 28.89M shares derived: average of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | 32.21M shares 10-Q · filed 2020-05-11 | 23.29M shares 10-Q · filed 2019-05-02 | -2.71M shares derived: average of 2 quarters · filed 2021-03-04 | 5.85M shares derived: average of 3 quarters · filed 2021-03-04 | 10.11M shares derived: average of 4 quarters · filed 2021-03-04 | |||
| 2018-12-31 | -37.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -7.33M shares derived: average of 2 quarters · filed 2021-03-04 | 2.74M shares derived: average of 3 quarters · filed 2021-03-04 | 6.47M shares 10-K · filed 2021-03-04 | 21.67M shares 10-K · filed 2019-02-28 | |||
| 2018-09-30 | 22.98M shares 10-Q · filed 2019-10-31 | 22.92M shares derived: average of 2 quarters · filed 2019-10-31 | 21.16M shares 10-Q · filed 2019-10-31 | 17.15M shares derived: average of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | 22.87M shares 10-Q · filed 2019-08-01 | 20.24M shares 10-Q · filed 2019-08-01 | 15.20M shares derived: average of 3 quarters · filed 2020-03-03 | 12.68M shares derived: average of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | 17.58M shares 10-Q · filed 2019-05-02 | 11.37M shares derived: average of 2 quarters · filed 2020-03-03 | 9.28M shares derived: average of 3 quarters · filed 2020-03-03 | 8.24M shares derived: average of 4 quarters · filed 2020-03-03 | ||||
| 2017-12-31 | 5.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | 5.13M shares derived: average of 2 quarters · filed 2020-03-03 | 5.12M shares derived: average of 3 quarters · filed 2020-03-03 | 5.11M shares 10-K · filed 2020-03-03 | ||||
| 2017-09-30 | 5.12M shares 10-Q · filed 2018-11-07 | 5.10M shares derived: average of 2 quarters · filed 2018-11-07 | 5.09M shares 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 5.09M shares 10-Q · filed 2018-08-01 | 5.08M shares 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | 5.07M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 4.99M shares 10-K · filed 2019-02-28 | |||||||
| 2015-12-31 | 4.74M shares 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |